1 – 10 of 40
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Nordic anal cancer (NOAC) group consensus guidelines for risk-adapted delineation of the elective clinical target volume in anal cancer
(
- Contribution to journal › Article
- 2021
-
Mark
Sarcopenia and dosimetric parameters in relation to treatment-related leukopenia and survival in anal cancer
(
- Contribution to journal › Article
-
Mark
Patterns of pathologic lymph nodes in anal cancer : a PET-CT-based analysis with implications for radiotherapy treatment volumes
(
- Contribution to journal › Article
- 2020
-
Mark
Palliative short-course hypofractionated radiotherapy followed by chemotherapy in esophageal adenocarcinoma : the phase II PALAESTRA trial
(
- Contribution to journal › Article
-
Mark
Evaluation of the stage classification of anal cancer by the TNM 8th version versus the TNM 7th version
(
- Contribution to journal › Article
-
Mark
Patterns of recurrence in anal cancer : A detailed analysis
(
- Contribution to journal › Article
-
Mark
Treatment-related leukopenia in anal cancer patients associated with worse outcome : results of a retrospective cohort study
(
- Contribution to journal › Letter
- 2019
-
Mark
Physical activity and survival following breast cancer
(
- Contribution to journal › Article
- 2018
-
Mark
Protein array profiling of circulating angiogenesis-related factors during bevacizumab containing treatment in metastatic colorectal cancer
(
- Contribution to journal › Article
-
Mark
Podocalyxin-like protein as a predictive biomarker for benefit of neoadjuvant chemotherapy in resectable gastric and esophageal adenocarcinoma
(
- Contribution to journal › Article